GSE202434 GSE202438 talazoparib 9 v 11 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE202434_GSE202438_talazoparib_9_v_11_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE202434_GSE202438_talazoparib_9_v_11_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE202434_GSE202438_talazoparib_9_v_11_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE202434_GSE202438_talazoparib_9_v_11_human_up.

Results found

Linked to

 

Label

Description

 

Gene

small nucleolar RNA host gene 29

Gene

zinc finger protein 883

Gene

CENPB DNA-binding domains containing 2, pseudogene

Gene

MIR193b-365a host gene

Gene

long intergenic non-protein coding RNA 1139

Gene

uncharacterized LOC100129434

Gene

H3 clustered histone 3

Gene

SPINT1 antisense RNA 1

Gene

TIAM1 antisense RNA 1

Gene

long intergenic non-protein coding RNA 1687

  • Gene

    small nucleolar RNA host gene 29


  • Gene

    zinc finger protein 883


  • Gene

    CENPB DNA-binding domains containing 2, pseudogene


  • Gene

    MIR193b-365a host gene


  • Gene

    long intergenic non-protein coding RNA 1139


  • Gene

    uncharacterized LOC100129434


  • Gene

    H3 clustered histone 3


  • Gene

    SPINT1 antisense RNA 1


  • Gene

    TIAM1 antisense RNA 1


  • Gene

    long intergenic non-protein coding RNA 1687

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.